Reported 120,999 shares, down 28,877 (19.3%) from the prior quarter.
Reported value -47.0%; share count -19.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 6909000 |
| 2021-12-31 | 1998000 |
| 2022-03-31 | 969000 |
| 2022-06-30 | 1084000 |
| 2022-09-30 | 569000 |
| 2022-12-31 | 509570 |
| 2023-03-31 | 353162 |
| 2023-06-30 | 386218 |
| 2023-09-30 | 286437 |
| 2023-12-31 | 434824 |
| 2024-03-31 | 283266 |
| 2024-06-30 | 150039 |
| 2024-09-30 | 25511 |
| 2024-12-31 | 31276 |
| 2025-03-31 | 26138 |
| 2025-06-30 | 20095 |
| 2025-09-30 | 19772 |
| 2025-12-31 | 5679 |
| 2026-03-31 | 4224 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -18,374 (-100.0%) | 0 | $0 | 2026-08-13 | |
| Q1 2026 | Reduced | 18,374 | -220 (-1.2%) | < 0.01% | $4,224 | 2026-05-15 | |
| Q4 2025 | Reduced | 18,594 | -8,917 (-32.4%) | < 0.01% | $5,679 | 2026-02-13 | |
| Q3 2025 | Reduced | 27,511 | -1,940 (-6.6%) | < 0.01% | $19,772 | 2025-11-14 | |
| Q2 2025 | Added | 29,451 | +760 (2.6%) | < 0.01% | $20,095 | 2025-08-15 | |
| Q1 2025 | Reduced | 28,691 | -2 (0.0%) | < 0.01% | $26,138 | 2025-05-15 | |
| Q4 2024 | Reduced | 28,693 | -4,998 (-14.8%) | < 0.01% | $31,276 | 2025-02-14 | |
| Q3 2024 | Reduced | 33,691 | -87,308 (-72.2%) | < 0.01% | $25,511 | 2024-11-14 | |
| Q2 2024 | Reduced | 120,999 | -28,877 (-19.3%) | < 0.01% | $150,039 | 2024-08-14 | |
| Q1 2024 | Reduced | 149,876 | -14,830 (-9.0%) | < 0.01% | $283,266 | 2024-05-15 | |
| Q4 2023 | Added | 164,706 | +40,168 (32.3%) | < 0.01% | $434,824 | 2024-02-13 | |
| Q3 2023 | Added | 124,538 | +18,725 (17.7%) | < 0.01% | $286,437 | 2023-11-15 | |
| Q2 2023 | Added | 105,813 | +6,888 (7.0%) | < 0.01% | $386,218 | 2023-08-14 | |
| Q1 2023 | Reduced | 98,925 | -79,871 (-44.7%) | < 0.01% | $353,162 | 2023-05-15 | |
| Q4 2022 | Reduced | 178,796 | -76,512 (-30.0%) | < 0.01% | $509,570 | 2023-02-14 | |
| Q3 2022 | Reduced | 255,308 | -179,700 (-41.3%) | < 0.01% | $569,000 | 2022-11-14 | |
| Q2 2022 | Added | 435,008 | +236,429 (119.1%) | < 0.01% | $1,084,000 | 2022-08-15 | |
| Q1 2022 | Added | 198,579 | +21,940 (12.4%) | < 0.01% | $969,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 176,639 | -297,494 (-62.7%) | < 0.01% | $1,998,000 | 2022-02-14 | |
| Q3 2021 | Added | 474,133 | +46,905 (11.0%) | < 0.01% | $6,909,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
97 managers reported CUE BIOPHARMA INC for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Bleichroeder LP | Added | 2,861,606 | +106,578 | 1.06% | $3,548,391 | 19 qtrs |
| Slate Path Capital LP | Unchanged | 2,402,455 | 0 | 0.06% | $2,979,044 | 20 qtrs |
| VANGUARD GROUP INC | Reduced | 2,031,421 | -251,941 | < 0.01% | $2,518,962 | 26 qtrs |
| BlackRock Inc | Reduced | 756,736 | -1,487,367 | < 0.01% | $938,353 | 26 qtrs |
| MILLENNIUM MANAGEMENT LLC | Added | 493,987 | +131,897 | < 0.01% | $612,544 | 17 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 492,456 | -346,075 | < 0.01% | $610,794 | 26 qtrs |
| Robertson Stephens Wealth Management LLC | Unchanged | 478,500 | 0 | 0.03% | $593,340 | 16 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 350,419 | -14,763 | < 0.01% | $434,519 | 26 qtrs |
| Good Life Advisors LLC | Added | 325,000 | +225,000 | 0.03% | $403,001 | 9 qtrs |
| GSA CAPITAL PARTNERS LLP | Added | 277,559 | +68,459 | 0.02% | $344,000 | 16 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 14, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 100,204
- Shared
- 300
- None
- 20,495
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.